Home2024December22FDA approves weight-loss drug Zepbound to treat sleep apnea – The Washington Post FDA approves weight-loss drug Zepbound to treat sleep apnea – The Washington Post December 22, 2024betadmin It marks the first medication for certain patients with the condition. #stockmarket #breaking
Stocks making the biggest moves midday: Biogen, Rivian, Bank of America, Airbnb & more – CNBC These are the stocks posting the largest moves in midday trading. #stockmarket #breaking
Walmart employees are now wearing body cameras in some stores – CNBC Walmart store associates are now using body cameras in some locations as retailers look to deter theft and make employees…